Sign in

CIK 0001678660

  • Non-accelerated filer
  • Smaller reporting company

Prelude Therapeutics Inc

Sign in to watch
Ticker
PRLD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811384762
Phone
+1 302-467-1280
Business address
175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
Former names
Prelude Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-04-07 Pierce Christopher EVP and Chief of Business Oper Exercise or conversion · Employee Stock Option (right to buy) −828 7,818
2021-04-07 Morosini Deborah EVP, Chief of Clinical Affairs Exercise or conversion +1,000 $1.89 $2K 1,444
2021-04-07 Morosini Deborah EVP, Chief of Clinical Affairs Sale −1,000 $40.04 $40K 444
2021-04-07 Morosini Deborah EVP, Chief of Clinical Affairs Exercise or conversion · Employee Stock Option (right to buy) −1,000 7,646
2021-04-07 Mauro David J Chief Medical Officer Exercise or conversion +15,383 $1.89 $29K 15,383
2021-04-07 Mauro David J Chief Medical Officer Sale −8,300 $39.03 $324K 7,083
2021-04-07 Mauro David J Chief Medical Officer Sale −7,083 $39.69 $281K 0
2021-04-07 Mauro David J Chief Medical Officer Exercise or conversion · Employee Stock Option (right to buy) −15,383 287,227
2021-01-27 BAKER BROS. ADVISORS LP Director Exercise or conversion +5,188 $12.85 $67K 876,061
2021-01-27 BAKER BROS. ADVISORS LP Director Exercise or conversion +5,188 $12.85 $67K 9,252,951
2021-01-27 BAKER BROS. ADVISORS LP Director Exercise or conversion · Non-Qualified Stock Options (right to buy) −5,188 41,500
2021-01-27 BAKER BROS. ADVISORS LP Director Exercise or conversion · Non-Qualified Stock Options (right to buy) −5,188 41,500
2021-01-11 BAKER BROS. ADVISORS LP Director Purchase · Non-Voting Common Stock +12,444 $60.00 $747K 509,480
2021-01-11 BAKER BROS. ADVISORS LP Director Purchase · Non-Voting Common Stock +154,222 $60.00 $9.3M 5,212,371
2021-01-11 ORBIMED ADVISORS LLC Director Purchase · Non-Voting Common Stock +41,700 $60.00 $2.5M 5,596,886
2021-01-11 Bonita David P Director Purchase · Non-Voting Common Stock +41,700 $60.00 $2.5M 5,596,886
2020-09-29 BAKER BROS. ADVISORS LP Director Conversion +329,478 350,169
2020-09-29 BAKER BROS. ADVISORS LP Director Conversion +2,965,263 3,151,483
2020-09-29 BAKER BROS. ADVISORS LP Director Conversion +370,552 720,721
2020-09-29 BAKER BROS. ADVISORS LP Director Conversion +4,047,634 7,199,117

Page 15 of 19 · 369 trades